semaglutide oral fda approval Accepts NDA Submission for 25 mg Rybelsus Wins FDA Label Update

GLP-1RAs may also delay gastric emptying, potentially leading to retained gastric contents and aspiration risk

Why MD Supervision Makes All the Difference Personalized Safety and Monitoring GLP-1 therapy isnt just about the medicationits about the whole journey

Discuss potential drug testing concerns with healthcare providers

Supporting bowel habits, maintaining adequate hydration and nutrition, and preserving muscle strength can help ensure that the benefits of GLP-1 therapy are maximized while minimizing potential pelvic floor challenges

We look forward to bringing this product to market in the very near future. About Orbicular Orbicular is an R&D focussed, partnership driven B2B specialty pharmaceutical platform, developing and licensing IP-owned assets in complex generics and advanced drug delivery systems across global markets